APA (7th ed.) Citation

Guler Kara, H., Dogan, E., Bozok, V., Aktan, C., Cakiroglu, E., Eroglu, Z., . . . Kosova, B. (2025). The G protein‐coupled receptor GPR89A is a novel potential therapeutic target to overcome cisplatin resistance in NSCLC Calu1 cells. FEBS Journal, 292(14), 3755. https://doi.org/10.1111/febs.70099

Chicago Style (17th ed.) Citation

Guler Kara, Hale, et al. "The G Protein‐coupled Receptor GPR89A Is a Novel Potential Therapeutic Target to Overcome Cisplatin Resistance in NSCLC Calu1 Cells." FEBS Journal 292, no. 14 (2025): 3755. https://doi.org/10.1111/febs.70099.

MLA (9th ed.) Citation

Guler Kara, Hale, et al. "The G Protein‐coupled Receptor GPR89A Is a Novel Potential Therapeutic Target to Overcome Cisplatin Resistance in NSCLC Calu1 Cells." FEBS Journal, vol. 292, no. 14, 2025, p. 3755, https://doi.org/10.1111/febs.70099.